Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,524,000 | 7,441,000 | 15,621,000 | 13,451,000 | 13,531,000 |
| Marketable Securities | 4,903,000 | 8,278,000 | 1,865,000 | 2,690,000 | 1,441,000 |
| Receivables | 6,484,000 | 6,626,000 | 7,184,000 | 7,672,000 | 8,261,000 |
| Inventories | 4,700,000 | 5,571,000 | 6,226,000 | 6,535,000 | 6,254,000 |
| Income taxes - deferred | 5,140,000 | 4,689,000 | 4,789,000 | 4,509,000 | 3,694,000 |
| TOTAL | $29,751,000 | $32,605,000 | $35,685,000 | $34,857,000 | $33,181,000 |
| Non-Current Assets | |||||
| PPE Net | 12,507,000 | 13,136,000 | 14,973,000 | 16,030,000 | 16,297,000 |
| Investments And Advances | 13,039,000 | 13,515,000 | 9,770,000 | 7,305,000 | 3,458,000 |
| Intangibles | 40,325,000 | 33,378,000 | 36,102,000 | 41,217,000 | 46,457,000 |
| Other Non-Current Assets | 6,055,000 | 5,533,000 | 9,115,000 | 6,723,000 | 5,735,000 |
| TOTAL | $71,926,000 | $65,562,000 | $69,960,000 | $71,275,000 | $71,947,000 |
| Total Assets | $101,677,000 | $98,167,000 | $105,645,000 | $106,132,000 | $105,128,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,533,000 | 2,625,000 | 2,274,000 | 1,753,000 | 2,023,000 |
| Accrued Expenses | 11,216,000 | 10,523,000 | 9,501,000 | 9,737,000 | 10,170,000 |
| TOTAL | $19,201,000 | $18,397,000 | $17,868,000 | $18,348,000 | $16,245,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,829,000 | 18,699,000 | 20,539,000 | 16,254,000 | 15,525,000 |
| Other Non-Current Liabilities | 7,328,000 | 7,799,000 | 8,023,000 | 10,196,000 | -120,000 |
| TOTAL | $37,709,000 | $30,979,000 | $35,451,000 | $32,321,000 | $31,940,000 |
| Total Liabilities | $56,910,000 | $49,376,000 | $53,319,000 | $50,669,000 | $48,185,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,775,259 | 2,838,193 | 2,940,622 | 3,022,367 | 3,044,008 |
| Common Shares | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 | 1,788,000 |
| Retained earnings | 45,348,000 | 46,021,000 | 39,257,000 | 39,985,000 | 38,990,000 |
| Other shareholders' equity | -4,057,000 | -4,179,000 | 364,000 | -2,239,000 | -706,000 |
| TOTAL | $44,767,000 | $48,791,000 | $52,326,000 | $55,463,000 | $56,943,000 |
| Total Liabilities And Equity | $101,677,000 | $98,167,000 | $105,645,000 | $106,132,000 | $105,128,000 |